- Home
- FINV vs VCEL Comparison
FINV vs VCEL Comparison
Compare FINV & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FINV
- VCEL
- Stock Information
- Founded
- FINV 2007
- VCEL 1989
- Country
- FINV China
- VCEL United States
- Employees
- FINV N/A
- VCEL N/A
- Industry
- FINV Finance: Consumer Services
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FINV Finance
- VCEL Health Care
- Exchange
- FINV Nasdaq
- VCEL Nasdaq
- Market Cap
- FINV 2.0B
- VCEL 2.1B
- IPO Year
- FINV N/A
- VCEL 1997
- Fundamental
- Price
- FINV $7.92
- VCEL $34.05
- Analyst Decision
- FINV Strong Buy
- VCEL Strong Buy
- Analyst Count
- FINV 2
- VCEL 6
- Target Price
- FINV $11.55
- VCEL $61.50
- AVG Volume (30 Days)
- FINV 2.3M
- VCEL 565.9K
- Earning Date
- FINV 08-20-2025
- VCEL 07-31-2025
- Dividend Yield
- FINV 3.57%
- VCEL N/A
- EPS Growth
- FINV 32.63
- VCEL 2045.40
- EPS
- FINV 1.49
- VCEL 0.13
- Revenue
- FINV $1,927,901,951.00
- VCEL $249,119,000.00
- Revenue This Year
- FINV $13.45
- VCEL $18.35
- Revenue Next Year
- FINV $9.59
- VCEL $22.47
- P/E Ratio
- FINV $5.23
- VCEL $256.98
- Revenue Growth
- FINV 7.84
- VCEL 16.13
- 52 Week Low
- FINV $5.14
- VCEL $33.09
- 52 Week High
- FINV $11.08
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- FINV 36.14
- VCEL 40.14
- Support Level
- FINV $7.74
- VCEL $33.34
- Resistance Level
- FINV $9.73
- VCEL $36.81
- Average True Range (ATR)
- FINV 0.39
- VCEL 1.36
- MACD
- FINV -0.10
- VCEL -0.13
- Stochastic Oscillator
- FINV 9.05
- VCEL 20.14
About FINV FinVolution Group
FinVolution Group is a provider of online consumer finance in China. The company offers various loan products, making financial services available to borrowers anytime, anywhere; designs a loan transaction process, and offers tailored risk-based pricing. It offers short-term loans to borrowers to meet immediate credit needs while allowing them to gradually establish their credit history through activities on the company's platform. The company generates revenues from fees charged to borrowers. The Group's long-lived assets are located in the PRC, and its revenues are derived from within the PRC.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.